| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ADHM.201500226 |
| P8608 | Fatcat ID | release_z3ctvpktkvf4lgwbqe6hz3zxvi |
| P698 | PubMed publication ID | 25973730 |
| P5875 | ResearchGate publication ID | 276410380 |
| P50 | author | Mato Knez | Q79804910 |
| Fan Yang | Q89214181 | ||
| Le Li | Q47412796 | ||
| Lianbing Zhang | Q47412806 | ||
| P2093 | author name string | Matthias Brandsch | |
| Regina Schöps | |||
| Alessandra Di Penta | |||
| José L Zugaza | |||
| Unai Carmona | |||
| P2860 | cites work | A novel receptor-mediated nuclear protein import pathway | Q24324050 |
| Structural Basis of Multiple Drug-Binding Capacity of the AcrB Multidrug Efflux Pump | Q27641199 | ||
| Ferritin is used for iron storage in bloom-forming marine pennate diatoms | Q27653003 | ||
| Intracellular CO release from composite of ferritin and ruthenium carbonyl complexes | Q27695737 | ||
| Viral vectors for gene transfer: a review of their use in the treatment of human diseases | Q28138453 | ||
| Ferritin light-chain subunits: key elements for the electron transfer across the protein cage | Q28250429 | ||
| Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation | Q28486241 | ||
| Scara5 is a ferritin receptor mediating non-transferrin iron delivery | Q28587430 | ||
| Ferritin, iron homeostasis, and oxidative damage1,2 1Guest Editor: Mario Comporti 2This article is part of a series of reviews on “Iron and Cellular Redox Status.” The full list of papers may be found on the homepage of the journal. | Q29399399 | ||
| Binding and uptake of H-ferritin are mediated by human transferrin receptor-1. | Q33734849 | ||
| Specific repression of beta-globin promoter activity by nuclear ferritin | Q33930020 | ||
| Nuclear pore complex is able to transport macromolecules with diameters of about 39 nm | Q33953659 | ||
| H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection. | Q34383748 | ||
| Dye-loaded ferritin nanocages for multimodal imaging and photothermal therapy | Q34430803 | ||
| RGD-modified apoferritin nanoparticles for efficient drug delivery to tumors | Q34652361 | ||
| Three-dimensional organotypic culture: experimental models of mammalian biology and disease | Q35155660 | ||
| Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging | Q35995110 | ||
| The nuclear ubiquitin-proteasome system | Q36474620 | ||
| Subcellular targeting strategies for drug design and delivery | Q37665298 | ||
| Nuclear ferritin: A new role for ferritin in cell biology | Q37719971 | ||
| In vivo gene delivery by nonviral vectors: overcoming hurdles? | Q38004708 | ||
| Transferrin-bearing polypropylenimine dendrimer for targeted gene delivery to the brain | Q38984282 | ||
| Targeted in vivo imaging of microscopic tumors with ferritin-based nanoprobes across biological barriers | Q39023387 | ||
| A bacterial protein enhances the release and efficacy of liposomal cancer drugs | Q40204842 | ||
| Chemokine CXCL12 induces binding of ferritin heavy chain to the chemokine receptor CXCR4, alters CXCR4 signaling, and induces phosphorylation and nuclear translocation of ferritin heavy chain | Q40216949 | ||
| Characterization of nuclear ferritin and mechanism of translocation. | Q40464676 | ||
| Doxorubicin paradoxically protects cardiomyocytes against iron-mediated toxicity: role of reactive oxygen species and ferritin | Q40596497 | ||
| Role of ferritin alterations in human breast cancer cells | Q43100521 | ||
| Ferritins for Chemistry and for Life | Q43236506 | ||
| Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system | Q46622772 | ||
| IRP1-independent alterations of cardiac iron metabolism in doxorubicin-treated mice | Q48498824 | ||
| Drug targeting. Breaking down barriers | Q48508319 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 1305-1310 | |
| P577 | publication date | 2015-05-13 | |
| P1433 | published in | Advanced Healthcare Materials | Q23928712 |
| P1476 | title | H-Chain Ferritin: A Natural Nuclei Targeting and Bioactive Delivery Nanovector | |
| P478 | volume | 4 |
| Q51550749 | Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system? |
| Q97530560 | Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model |
| Q64117007 | Cryo-EM structure of the human ferritin–transferrin receptor 1 complex |
| Q91183727 | Encapsulation of the Dinuclear Trithiolato-Bridged Arene Ruthenium Complex Diruthenium-1 in an Apoferritin Nanocage: Structure and Cytotoxicity |
| Q47601030 | Ferritin nanocages loaded with gold ions induce oxidative stress and apoptosis in MCF-7 human breast cancer cells |
| Q88011808 | Ferritin-based drug delivery systems: Hybrid nanocarriers for vascular immunotargeting |
| Q41309782 | H-Ferritin-nanocaged olaparib: a promising choice for both BRCA-mutated and sporadic triple negative breast cancer |
| Q54236664 | In vivo guiding nitrogen-doped carbon nanozyme for tumor catalytic therapy. |
| Q36156185 | LC-MS/MS method development for quantification of doxorubicin and its metabolite 13-hydroxy doxorubicin in mice biological matrices: Application to a pharmaco-delivery study |
| Q39076542 | Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger |
| Q37702718 | Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity. |
| Q45858764 | Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin |
| Q41183225 | Therapeutic Efficacy of the Novel Stimuli-Sensitive Nano-Ferritins Containing Doxorubicin in a Head and Neck Cancer Model. |
Search more.